Brainsway Ltd. — Director's Dealing 2026

Jun 3, 2026

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden hours per response	0.5
1. Name and Address of Reporting Person Roth Yiftach	2. Issuer Name and Ticker or Trading Symbol Brainsway Ltd. [BWAY] 2a. Foreign Trading Symbol
---	---
(Last)	(First)
16 HARTUM STREET, RAD TOWER, 14TH FLOOR HAR HAHOTZVIM
(Street)
JERUSALEM	9777516
(City)	(State)
ISRAEL
(Country)
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---	---
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)
Ordinary Shares(1)
Ordinary Shares(1)
Ordinary Shares(1)
Ordinary Shares(1)
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. The sale price was NIS 43.64 per share.
3. This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.
4. The sale price was NIS 43.45 per share.
5. The sale price was NIS 43 per share.
6. The sale price was NIS 42.0035 per share.

/s/ Yiftach Roth

** Signature of Reporting Person

06/03/2026

Date

---

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78f(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.